Clinical Trials · NCT00000325

Psychostimulant Abuse - Novel Treatment Approaches - 1

CompletedPhase 1Gonadorelin (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
National Institute on Drug Abuse (NIDA)
Enrollment
0
Start date
Not specified
Locations
1 site, United States
Primary endpoint
Study in Cocaine-Related Disorders
View Gonadorelin compound reference